Heart Failure : The Expert's Approach

個数:

Heart Failure : The Expert's Approach

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 584 p.
  • 言語 ENG
  • 商品コード 9789350909492
  • DDC分類 616.129

Full Description

Heart failure is a serious condition caused by the heart failing to pump enough blood around the body at the right pressure. It usually occurs because the heart muscle has become too weak or stiff to work properly, most commonly caused by heart attack, high blood pressure or cardiomyopathy (heart disease).

This book is a comprehensive guide to heart failure for clinicians. Divided into six sections, the book begins with emergency management, then discusses heart failure in both in-patient and out-patient hospital care. A complete chapter is dedicated to the role of biomarkers at different stages of heart failure.

Special issues such as diabetes management and heart failure, geographical variations, and chronic heart failure in geriatric patients, are discussed in depth. The final sections examine advanced heart failure and the diagnosis and management of cardiomyopathies.

Written by experienced authors from the University of California and the University of Athens, this manual includes more than 175 images and illustrations to enhance learning.

Key points

Comprehensive guide to heart failure
Covers role of biomarkers at different stages of heart failure
Complete section dedicated to diagnosis and management of cardiomyopathies
Experienced author team from USA and Greece

Contents

Section 1: The Emergency Department

How to Evaluate Dyspnea in the Emergency Department
Heart Failure Disposition: When to Admit, When to Observe, and When to Discharge Home
The Treatment of Acute Heart Failure in the Emergency Department
Management of Atrial Fibrillation in Patients with Heart Failure and Preserved and
Low Ejection Fractions
How to Use Natriuretic Peptides in the Emergency Department
How to Use New Biomarkers in the Emergency Department
The Role of Ultrasound in the Management of Acute Heart Failure
Use of Bioelectrical Impedance Vector Analysis in the Dyspneic Patient
Mechanical Ventilation in Acute Heart Failure: The Role of Noninvasive Ventilation
Emergency Department Observation Unit: Management of Congestive Heart Failure
When to Employ Cardiac Magnetic Resonance Imaging and Cardiac Computed Tomography in the Evaluation of Heart Failure
When to Discharge the Heart Failure Patient

 

Section 2: Heart Failure in the Hospital

How to Use Natriuretic Peptides in the Inpatient Setting?
Approaches to Diuretics in the Hospital
Vasodilators in Acute Heart Failure
When and How to Use Inotropes?
New Cardiovascular Disease Biomarkers in Hospital Medicine: Neutrophil Gelatinase-associated Lipocalin
Practical Approach to Hyponatremia in Heart Failure
Heart Failure and Acute Coronary Syndrome
The ABCs of Isolated Venovenous Ultrafiltration in Fluid-overloaded Heart Failure Patients
Who Should Receive a Pulmonary Artery Catheter

 

Section 3: Chronic Heart Failure in the Outpatient Setting

Outpatient Follow-up—What Should We Monitor
Echocardiography: Getting It Right
A Practical Guide for Reducing Readmissions in Heart Failure
Initiation of Angiotensin-converting Enzyme Inhibitors and Beta Blockers in Heart Failure: Putting Evidence into Practice
Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and a Reduced Left Ventricular Ejection Fraction: How to Do It Right
Atrial Fibrillation Done Right
Ventricular Tachycardia Done Right
Issues in Anticoagulation
Management of the Patient with Heart Failure with Preserved Ejection Fraction
Implantable Cardioverter-defibrillator and Cardiac Resynchronization Therapy in
Heart Failure Patients: How to Choose the Right Device for the Right Patients
Clinical Decision-making in the Outpatient Setting: The Use of Galectin-3
Guiding Heart Failure Care with Natriuretic Peptides
ST2: How to Really Do It Right
Using Cardiac Troponin to Assist in the Management of Patients with Congestive Heart Failure—A Practical Guide
Biomarkers on the Horizon for Chronic Heart Failure

 

Section 4: Special Issues in Heart Failure

Sex Differences in Heart Failure: Implications for Clinical Practice
Chronic Heart Failure in Geriatric Patients
How to Diagnose and Treat Anemia in Patients with Heart Failure
Diabetes Management in Heart Failure
Heart Failure in Europe
Heart Failure in Southeast Asia
Heart Failure in India
Heart Failure in India: Clinical Perspective
Heart Failure in China
Heart Failure from the US Veterans Health Administration Perspective: A Patient-centered Approach to Care
Heart Failure in the Nursing Home Setting
Heart Failure from the Nursing Perspective
Developing Heart Failure Service in a Developing Nation: Borneo Malaysia Perspective

 

Section 5: Advanced Heart Failure

Approach to the End-stage Heart Failure Patient
Left Ventricular Assist Device Versus Transplantation: How to Decide
Approach to Left Ventricular Assist Devices and Follow-up in Advanced Congestive Heart Failure
How to Approach Palliative and End-of-life Care
Percutaneous Mechanical Circulatory Support in Cardiogenic Shock

 

Section 6: Cardiomyopathies: Practical Recommendations to Diagnosis and Management

New Onset Cardiomyopathy: Biopsy or MRI and Other Imaging Modalities
Hypertrophic Cardiomyopathy
Takotsubo Cardiomyopathy
Myocarditis
When is Genetic Testing Necessary?
AIDS-induced Cardiac Abnormalities and Heart Failure
Prohormone Levels in Heart Failure

最近チェックした商品